Published by Coherent Market Insights
Posted on September 29, 2021
3 min readLast updated: February 1, 2026
The telerehabilitation systems market is set to grow due to novel virtual rehabilitation solutions and increased demand during the pandemic.
Telerehabilitation is one of the safest ways to provide recovery services over a telecommunications network and the internet during this pandemic. Telerehabilitation may include counselling to people who are unable to go to a facility due to a disability or travel time. People would prefer this service through webcams, videoconferencing, phone lines, videophones, and webpages with rich Internet applications in this situation, which is expected to increase demand for telerehabilitation systems.
The full version of the report will examine the effect of COVID-19 and expected changes on the industry’s future outlook, taking into account political, economic, social, and technical factors.
Over the forecast period (2020-2027), the telerehabilitation systems market is projected to have a valuation of US$ 201.8 million in 2020 and is anticipated to manifest a CAGR of 13.4%.
Get a Sample Copy of the Telerehabilitation Systems market Report 2021 @
https://www.coherentmarketinsights.com/insight/request-sample/3842
Approvals and launch of telerehabilitation and online rehabilitation systems is expected to fuel growth of the global telerehabilitation systems during the forecast period.
The industry’s major players are working on new virtual recovery and telerehabilitation systems and bringing them to market. During the forecast period, the acceptance and launch of such advanced systems in the market are expected to significantly drive growth of the global telerehabilitation systems market and create a favorable environment for the telerehabilitation systems market to expand. In March 2018, Reflexion Health, Inc., a digital health solution company headquartered in the U.S., unveiled its next-generation solutions for patients and clinicians called VERAHome and VERAClinic. In the United States, VERAHome and VERAClinic are focused on the company’s FDA-approved Virtual Exercise Rehabilitation Assistant (VERA).
Moreover, major industry players are working to extend the use of virtual recovery services. The U.S. Food and Drug Administration (FDA) granted Reflexion Health, Inc. 510(k) clearance in June 2019 for the use of its Virtual Exercise Rehabilitation Assistant (VERA) interactive physical therapy platform in rehabilitating the trunk and upper extremities. VERA had previously been approved by the US Food and Drug Administration (FDA) for the treatment of lower extremity conditions such as knee and hip replacement surgery.
MindMaze’s Immersive Virtual Reality (IVR) therapy solution, MindMotionPRO, for neurological rehabilitation earned CE marking in February 2016. MindMotionPRO is a hospital-based rehabilitation solution for neurological patients who need early motor intervention.
Major Players in Telerehabilitation Systems Market
Reflexion Health, Inc., 270 Vision Ltd., CoRehab srl, Hinge Health, Inc., SWORD Health, S.A., MIRA Rehab Limited, re.flex, Neuro Rehab VR, Evolv Rehabilitation Technologies S.L., Yancheng Tianrun Medical Technology Co., Ltd., Tyromotion GmbH, Brontes Processing Ltd., Bridgeway Senior Healthcare, Rehametrics, Geminus-Qhom, MindMaze, DIH Medical, and Doctor Kinetic.
Ask for PDF sample copy of the Telerehabilitation Systems market report @
https://www.coherentmarketinsights.com/insight/request-pdf/3842
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
The post Telerehabilitation Systems Market – The launch and approvals of novel virtual rehabilitation by manufacturers is expected to boost the growth of the market appeared first on Gatorledger.
The article discusses the growth of the telerehabilitation systems market driven by new virtual rehabilitation solutions.
The market is projected to grow at a CAGR of 13.4% from 2020 to 2027, reaching a valuation of US$ 201.8 million in 2020.
FDA approvals, the launch of new systems, and increased demand due to COVID-19 are key growth drivers.
Explore more articles in the Research Reports category
